Epicatechin-(4beta->8)-epigallocatechin 3'-gallate

Details

Top
Internal ID e65b91d2-245b-4957-9f67-626b3776b24e
Taxonomy Phenylpropanoids and polyketides > Flavonoids > Biflavonoids and polyflavonoids
IUPAC Name [(2R,3R)-8-[(2R,3R,4R)-2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-4-yl]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate
SMILES (Canonical) C1C(C(OC2=C1C(=CC(=C2C3C(C(OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C(=C6)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O
SMILES (Isomeric) C1[C@H]([C@H](OC2=C1C(=CC(=C2[C@@H]3[C@H]([C@H](OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C(=C6)O)O)O)OC(=O)C7=CC(=C(C(=C7)O)O)O
InChI InChI=1S/C37H30O17/c38-15-8-20(42)28-26(9-15)52-35(12-1-2-17(39)19(41)3-12)33(50)30(28)29-21(43)11-18(40)16-10-27(53-37(51)14-6-24(46)32(49)25(47)7-14)34(54-36(16)29)13-4-22(44)31(48)23(45)5-13/h1-9,11,27,30,33-35,38-50H,10H2/t27-,30-,33-,34-,35-/m1/s1
InChI Key BUOLDWJIICQRBU-RGOYVLDUSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C37H30O17
Molecular Weight 746.60 g/mol
Exact Mass 746.14829948 g/mol
Topological Polar Surface Area (TPSA) 308.00 Ų
XlogP 3.20
Atomic LogP (AlogP) 3.68
H-Bond Acceptor 17
H-Bond Donor 13
Rotatable Bonds 5

Synonyms

Top
DTXSID901099079
Epicatechin-(4beta->8)-epigallocatechin 3'-gallate
(2R)-2alpha-(3,4,5-Trihydroxyphenyl)-8-[[(2R)-2alpha-(3,4-dihydroxyphenyl)-3alpha,5,7-trihydroxy-3,4-dihydro-2H-1-benzopyran]-4beta-yl]-3,4-dihydro-2H-1-benzopyran-3alpha,5,7-triol 3-(3,4,5-trihydroxybenzoate)
(2R,2'R,3R,3'R,4R)-2-(3,4-Dihydroxyphenyl)-3,3',4,4'-tetrahydro-3,5,5',7,7'-pentahydroxy-2'-(3,4,5-trihydroxyphenyl)[4,8'-bi-2H-1-benzopyran]-3'-yl 3,4,5-trihydroxybenzoate
126715-89-7

2D Structure

Top
2D Structure of Epicatechin-(4beta->8)-epigallocatechin 3'-gallate

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.8063 80.63%
Caco-2 - 0.9132 91.32%
Blood Brain Barrier - 0.8250 82.50%
Human oral bioavailability - 0.7143 71.43%
Subcellular localzation Mitochondria 0.6485 64.85%
OATP2B1 inhibitior - 0.7027 70.27%
OATP1B1 inhibitior + 0.8528 85.28%
OATP1B3 inhibitior - 0.4057 40.57%
MATE1 inhibitior - 0.8000 80.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior + 0.8943 89.43%
P-glycoprotein inhibitior + 0.7069 70.69%
P-glycoprotein substrate - 0.6548 65.48%
CYP3A4 substrate + 0.6743 67.43%
CYP2C9 substrate - 0.7962 79.62%
CYP2D6 substrate - 0.7126 71.26%
CYP3A4 inhibition - 0.7658 76.58%
CYP2C9 inhibition - 0.8173 81.73%
CYP2C19 inhibition - 0.7636 76.36%
CYP2D6 inhibition - 0.9515 95.15%
CYP1A2 inhibition - 0.8594 85.94%
CYP2C8 inhibition + 0.8162 81.62%
CYP inhibitory promiscuity - 0.8411 84.11%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 1.0000 100.00%
Carcinogenicity (trinary) Non-required 0.6439 64.39%
Eye corrosion - 0.9907 99.07%
Eye irritation - 0.8812 88.12%
Skin irritation - 0.6484 64.84%
Skin corrosion - 0.9586 95.86%
Ames mutagenesis + 0.5800 58.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8650 86.50%
Micronuclear + 0.8659 86.59%
Hepatotoxicity - 0.5000 50.00%
skin sensitisation - 0.8408 84.08%
Respiratory toxicity + 0.7000 70.00%
Reproductive toxicity + 0.7889 78.89%
Mitochondrial toxicity + 0.6500 65.00%
Nephrotoxicity - 0.7292 72.92%
Acute Oral Toxicity (c) IV 0.3703 37.03%
Estrogen receptor binding + 0.7906 79.06%
Androgen receptor binding + 0.8033 80.33%
Thyroid receptor binding + 0.5658 56.58%
Glucocorticoid receptor binding + 0.5807 58.07%
Aromatase binding - 0.5814 58.14%
PPAR gamma + 0.6762 67.62%
Honey bee toxicity - 0.7491 74.91%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity + 0.6100 61.00%
Fish aquatic toxicity + 0.9003 90.03%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 99.64% 91.11%
CHEMBL1951 P21397 Monoamine oxidase A 98.71% 91.49%
CHEMBL3194 P02766 Transthyretin 96.38% 90.71%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.64% 96.09%
CHEMBL3137262 O60341 LSD1/CoREST complex 92.67% 97.09%
CHEMBL3475 P05121 Plasminogen activator inhibitor-1 92.53% 83.00%
CHEMBL1929 P47989 Xanthine dehydrogenase 91.32% 96.12%
CHEMBL2535 P11166 Glucose transporter 91.28% 98.75%
CHEMBL1806 P11388 DNA topoisomerase II alpha 91.19% 89.00%
CHEMBL3004 P33527 Multidrug resistance-associated protein 1 90.95% 96.37%
CHEMBL335 P18031 Protein-tyrosine phosphatase 1B 89.51% 95.17%
CHEMBL4040 P28482 MAP kinase ERK2 89.14% 83.82%
CHEMBL3060 Q9Y345 Glycine transporter 2 89.09% 99.17%
CHEMBL1293249 Q13887 Kruppel-like factor 5 88.77% 86.33%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 87.90% 99.23%
CHEMBL4208 P20618 Proteasome component C5 86.43% 90.00%
CHEMBL1860 P10827 Thyroid hormone receptor alpha 84.69% 99.15%
CHEMBL5339 Q5NUL3 G-protein coupled receptor 120 84.31% 95.78%
CHEMBL5608 Q16288 NT-3 growth factor receptor 83.97% 95.89%
CHEMBL2581 P07339 Cathepsin D 83.72% 98.95%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 83.45% 95.56%
CHEMBL236 P41143 Delta opioid receptor 82.69% 99.35%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 81.32% 94.00%
CHEMBL245 P20309 Muscarinic acetylcholine receptor M3 81.31% 97.53%

Cross-Links

Top
PubChem 11513300
NPASS NPC194264
LOTUS LTS0107649
wikiData Q102165851